Quantcast

Latest Postherpetic neuralgia Stories

2011-05-02 05:00:00

VANCOUVER, British Columbia, May 2, 2011 /PRNewswire/ -- Xenon Pharmaceuticals Inc. (Xenon) announced today that its novel ointment XEN402 demonstrated significant and clinically meaningful reductions in pain in patients with Post Herpetic Neuralgia (PHN). Xenon is developing XEN402 as a topical treatment for a variety of painful disorders including PHN, as it specifically targets sodium channels such as Nav1.7. Sodium channels are highly expressed in sensory nerve endings and can be...

2011-04-29 06:05:00

SAN MATEO, Calif., April 29, 2011 /PRNewswire/ -- First Quarter 2011 Highlights: Qutenza® (capsaicin) 8% patch purchased by 321 institutions, up from 239 in Q4 2010 Revenue of $3.2 million including $0.6 million U.S. Qutenza product revenue Operational focus enables lower planned expense growth in 2011 Qutenza sales initiated in Poland and Czech Republic by Astellas NGX-1998 Phase 2 clinical trial continues in postherpetic neuralgia (PHN) patients surpassing 65%...

2011-04-29 06:00:00

SAN MATEO, Calif., April 29, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that long time CEO Anthony DiTonno will retire by December 31, 2011. The Board of Directors has initiated a formal executive search for a Chief Executive Officer. Anthony DiTonno commented, "I have been CEO of NeurogesX for more than eight years and we have accomplished the objectives I...

2011-04-28 07:00:00

SAN MATEO, Calif., April 28, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent entitled, "Methods and Compositions for Administration of TRPV1 Agonists." The allowed claims include method of use, formulation and system claims. The patent scheduled to issue from this...

2011-04-21 13:15:00

SAN MATEO, Calif., April 21, 2011 /PRNewswire/ -- NeurogesX, Inc. (NASDAQ: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that it will host an investor day on Friday, April 29, 2011, from 8:15 am - 11:00 am EDT at The New York Palace Hotel in New York. As part of the presentation, management will announce and review results for the first quarter ended March 31, 2011. The Investor Day will be webcast live...

2011-03-30 15:05:00

SAN MATEO, Calif., March 30, 2011 /PRNewswire/ -- Recent Highlights: Qutenza(®) (capsaicin) 8% patch launch in US by NeurogesX sales force drives early adoption by large US institutions; 238 hospitals purchased as of 4Q10, up 54% from 3Q10 Medicare Part B coverage confirmed Q4 2010 revenue totaled $2.3 million including $0.5 million U.S. Qutenza product revenue EU launch by Astellas advancing, with Qutenza available in 17 countries at December 31, 2010 NGX-1998 Phase 2...

2011-02-28 16:21:00

SAN MATEO, Calif., Feb. 28, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at three upcoming investor conferences: The Citi 2011 Global Health Care Conference, March 1 - 3, in New York, NY; The Cowen and Company 31st Annual Health Care Conference, March 7 - 9, in Boston, MA; and The...

2011-02-28 07:05:00

STAINES, England, February 28, 2011 /PRNewswire-FirstCall/ -- - Decision to Reimburse Qutenza(TM) (capsaicin 8% w/w dermal patch) by Sweden's Dental and Pharmaceutical Benefits Agency (Tand-och Lakemedelsformansverket) Gives new Option to Patients Living With Difficult-to-Treat Condition Patients in Sweden living with peripheral neuropathic pain are set to gain access to a new treatment option which can provide pain relief for up to three months following a single 30- or...

2011-02-09 07:30:00

SAN MATEO, Calif., Feb. 9, 2011 /PRNewswire/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on February 14, 2011 at 4:30 p.m. ET (1:30 p.m. PT) to provide an update on the U.S. commercial launch of Qutenza® (capsaicin) 8% patch for the management of neuropathic pain associated with postherpetic neuralgia (PHN). NeurogesX will highlight...

2011-02-09 06:48:00

PRINCETON, N.J., Feb. 9, 2011 /PRNewswire/ -- Protect Pharmaceutical Corporation (OTC Bulletin Board: PRTT) announced today that it has completed the sale of two patents and patents-applications to Grunenthal GmbH, a German specialty pharmaceutical company that is a pioneer in pain drug discovery and research. The patent portfolio includes innovative pain drugs that address the large and underserved pain market. Ram Sesha, Protect's Chief Operating Officer, said, "We are very happy to see...


Latest Postherpetic neuralgia Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »
Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related